The global CAR-T Cell Therapy Solution market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for CAR-T Cell Therapy Solution is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for CAR-T Cell Therapy Solution is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for CAR-T Cell Therapy Solution is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key CAR-T Cell Therapy Solution players cover Thermo Fisher Scientific, Q2 Solutions, Agilent Technologies, Genscript Biotech, Sino Biological, Nuowei Biotechnology, Novartis, JW Therapeutics and Sorrento Therapeutics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)' newest research report, the “CAR-T Cell Therapy Solution Industry Forecast” looks at past sales and reviews total world CAR-T Cell Therapy Solution sales in 2022, providing a comprehensive analysis by region and market sector of projected CAR-T Cell Therapy Solution sales for 2023 through 2029. With CAR-T Cell Therapy Solution sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world CAR-T Cell Therapy Solution industry.
This Insight Report provides a comprehensive analysis of the global CAR-T Cell Therapy Solution landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on CAR-T Cell Therapy Solution portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global CAR-T Cell Therapy Solution market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for CAR-T Cell Therapy Solution and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global CAR-T Cell Therapy Solution.
This report presents a comprehensive overview, market shares, and growth opportunities of CAR-T Cell Therapy Solution market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
CD19 CAR Cell Therapy
BCMA CAR Cell Therapy
Segmentation by application
Leukemia
Lymphoma
Myeloma
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Q2 Solutions
Agilent Technologies
Genscript Biotech
Sino Biological
Nuowei Biotechnology
Novartis
JW Therapeutics
Sorrento Therapeutics
Gilead Sciences

1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global CAR-T Cell Therapy Solution Market Size 2018-2029 2.1.2 CAR-T Cell Therapy Solution Market Size CAGR by Region 2018 VS 2022 VS 2029 2.2 CAR-T Cell Therapy Solution Segment by Type 2.2.1 CD19 CAR Cell Therapy 2.2.2 BCMA CAR Cell Therapy 2.3 CAR-T Cell Therapy Solution Market Size by Type 2.3.1 CAR-T Cell Therapy Solution Market Size CAGR by Type (2018 VS 2022 VS 2029) 2.3.2 Global CAR-T Cell Therapy Solution Market Size Market Share by Type (2018-2023) 2.4 CAR-T Cell Therapy Solution Segment by Application 2.4.1 Leukemia 2.4.2 Lymphoma 2.4.3 Myeloma 2.4.4 Others 2.5 CAR-T Cell Therapy Solution Market Size by Application 2.5.1 CAR-T Cell Therapy Solution Market Size CAGR by Application (2018 VS 2022 VS 2029) 2.5.2 Global CAR-T Cell Therapy Solution Market Size Market Share by Application (2018-2023) 3 CAR-T Cell Therapy Solution Market Size by Player 3.1 CAR-T Cell Therapy Solution Market Size Market Share by Players 3.1.1 Global CAR-T Cell Therapy Solution Revenue by Players (2018-2023) 3.1.2 Global CAR-T Cell Therapy Solution Revenue Market Share by Players (2018-2023) 3.2 Global CAR-T Cell Therapy Solution Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 CAR-T Cell Therapy Solution by Regions 4.1 CAR-T Cell Therapy Solution Market Size by Regions (2018-2023) 4.2 Americas CAR-T Cell Therapy Solution Market Size Growth (2018-2023) 4.3 APAC CAR-T Cell Therapy Solution Market Size Growth (2018-2023) 4.4 Europe CAR-T Cell Therapy Solution Market Size Growth (2018-2023) 4.5 Middle East & Africa CAR-T Cell Therapy Solution Market Size Growth (2018-2023) 5 Americas 5.1 Americas CAR-T Cell Therapy Solution Market Size by Country (2018-2023) 5.2 Americas CAR-T Cell Therapy Solution Market Size by Type (2018-2023) 5.3 Americas CAR-T Cell Therapy Solution Market Size by Application (2018-2023) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC CAR-T Cell Therapy Solution Market Size by Region (2018-2023) 6.2 APAC CAR-T Cell Therapy Solution Market Size by Type (2018-2023) 6.3 APAC CAR-T Cell Therapy Solution Market Size by Application (2018-2023) 6.4 China 6.5 Japan 6.6 Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe CAR-T Cell Therapy Solution by Country (2018-2023) 7.2 Europe CAR-T Cell Therapy Solution Market Size by Type (2018-2023) 7.3 Europe CAR-T Cell Therapy Solution Market Size by Application (2018-2023) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa CAR-T Cell Therapy Solution by Region (2018-2023) 8.2 Middle East & Africa CAR-T Cell Therapy Solution Market Size by Type (2018-2023) 8.3 Middle East & Africa CAR-T Cell Therapy Solution Market Size by Application (2018-2023) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Global CAR-T Cell Therapy Solution Market Forecast 10.1 Global CAR-T Cell Therapy Solution Forecast by Regions (2024-2029) 10.1.1 Global CAR-T Cell Therapy Solution Forecast by Regions (2024-2029) 10.1.2 Americas CAR-T Cell Therapy Solution Forecast 10.1.3 APAC CAR-T Cell Therapy Solution Forecast 10.1.4 Europe CAR-T Cell Therapy Solution Forecast 10.1.5 Middle East & Africa CAR-T Cell Therapy Solution Forecast 10.2 Americas CAR-T Cell Therapy Solution Forecast by Country (2024-2029) 10.2.1 United States CAR-T Cell Therapy Solution Market Forecast 10.2.2 Canada CAR-T Cell Therapy Solution Market Forecast 10.2.3 Mexico CAR-T Cell Therapy Solution Market Forecast 10.2.4 Brazil CAR-T Cell Therapy Solution Market Forecast 10.3 APAC CAR-T Cell Therapy Solution Forecast by Region (2024-2029) 10.3.1 China CAR-T Cell Therapy Solution Market Forecast 10.3.2 Japan CAR-T Cell Therapy Solution Market Forecast 10.3.3 Korea CAR-T Cell Therapy Solution Market Forecast 10.3.4 Southeast Asia CAR-T Cell Therapy Solution Market Forecast 10.3.5 India CAR-T Cell Therapy Solution Market Forecast 10.3.6 Australia CAR-T Cell Therapy Solution Market Forecast 10.4 Europe CAR-T Cell Therapy Solution Forecast by Country (2024-2029) 10.4.1 Germany CAR-T Cell Therapy Solution Market Forecast 10.4.2 France CAR-T Cell Therapy Solution Market Forecast 10.4.3 UK CAR-T Cell Therapy Solution Market Forecast 10.4.4 Italy CAR-T Cell Therapy Solution Market Forecast 10.4.5 Russia CAR-T Cell Therapy Solution Market Forecast 10.5 Middle East & Africa CAR-T Cell Therapy Solution Forecast by Region (2024-2029) 10.5.1 Egypt CAR-T Cell Therapy Solution Market Forecast 10.5.2 South Africa CAR-T Cell Therapy Solution Market Forecast 10.5.3 Israel CAR-T Cell Therapy Solution Market Forecast 10.5.4 Turkey CAR-T Cell Therapy Solution Market Forecast 10.5.5 GCC Countries CAR-T Cell Therapy Solution Market Forecast 10.6 Global CAR-T Cell Therapy Solution Forecast by Type (2024-2029) 10.7 Global CAR-T Cell Therapy Solution Forecast by Application (2024-2029) 11 Key Players Analysis 11.1 Thermo Fisher Scientific 11.1.1 Thermo Fisher Scientific Company Information 11.1.2 Thermo Fisher Scientific CAR-T Cell Therapy Solution Product Offered 11.1.3 Thermo Fisher Scientific CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023) 11.1.4 Thermo Fisher Scientific Main Business Overview 11.1.5 Thermo Fisher Scientific Latest Developments 11.2 Q2 Solutions 11.2.1 Q2 Solutions Company Information 11.2.2 Q2 Solutions CAR-T Cell Therapy Solution Product Offered 11.2.3 Q2 Solutions CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023) 11.2.4 Q2 Solutions Main Business Overview 11.2.5 Q2 Solutions Latest Developments 11.3 Agilent Technologies 11.3.1 Agilent Technologies Company Information 11.3.2 Agilent Technologies CAR-T Cell Therapy Solution Product Offered 11.3.3 Agilent Technologies CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023) 11.3.4 Agilent Technologies Main Business Overview 11.3.5 Agilent Technologies Latest Developments 11.4 Genscript Biotech 11.4.1 Genscript Biotech Company Information 11.4.2 Genscript Biotech CAR-T Cell Therapy Solution Product Offered 11.4.3 Genscript Biotech CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023) 11.4.4 Genscript Biotech Main Business Overview 11.4.5 Genscript Biotech Latest Developments 11.5 Sino Biological 11.5.1 Sino Biological Company Information 11.5.2 Sino Biological CAR-T Cell Therapy Solution Product Offered 11.5.3 Sino Biological CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023) 11.5.4 Sino Biological Main Business Overview 11.5.5 Sino Biological Latest Developments 11.6 Nuowei Biotechnology 11.6.1 Nuowei Biotechnology Company Information 11.6.2 Nuowei Biotechnology CAR-T Cell Therapy Solution Product Offered 11.6.3 Nuowei Biotechnology CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023) 11.6.4 Nuowei Biotechnology Main Business Overview 11.6.5 Nuowei Biotechnology Latest Developments 11.7 Novartis 11.7.1 Novartis Company Information 11.7.2 Novartis CAR-T Cell Therapy Solution Product Offered 11.7.3 Novartis CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023) 11.7.4 Novartis Main Business Overview 11.7.5 Novartis Latest Developments 11.8 JW Therapeutics 11.8.1 JW Therapeutics Company Information 11.8.2 JW Therapeutics CAR-T Cell Therapy Solution Product Offered 11.8.3 JW Therapeutics CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023) 11.8.4 JW Therapeutics Main Business Overview 11.8.5 JW Therapeutics Latest Developments 11.9 Sorrento Therapeutics 11.9.1 Sorrento Therapeutics Company Information 11.9.2 Sorrento Therapeutics CAR-T Cell Therapy Solution Product Offered 11.9.3 Sorrento Therapeutics CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023) 11.9.4 Sorrento Therapeutics Main Business Overview 11.9.5 Sorrento Therapeutics Latest Developments 11.10 Gilead Sciences 11.10.1 Gilead Sciences Company Information 11.10.2 Gilead Sciences CAR-T Cell Therapy Solution Product Offered 11.10.3 Gilead Sciences CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023) 11.10.4 Gilead Sciences Main Business Overview 11.10.5 Gilead Sciences Latest Developments 12 Research Findings and Conclusion